JiangXi Tianxin Pharmaceutical Co., Ltd. (SHA:603235)

SHA:603235 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,368	1,078	2,308	2,070	717.08	1,019
Trading Asset Securities	157.77	481.69	-	230	-	-
Cash & Short-Term Investments	1,525	1,560	2,308	2,300	717.08	1,019
Cash Growth	-12.58%	-32.40%	0.35%	220.73%	-29.65%	-3.64%
Accounts Receivable	333.31	414.28	284.34	357.31	418.96	275.61
Other Receivables	3.35	1.4	1.7	2.03	2.23	12.89
Receivables	336.66	415.68	286.05	359.35	421.19	288.51
Inventory	550.74	589.23	478.97	470.63	405.54	330.4
Other Current Assets	175.21	130.46	48.47	36.4	35.58	7.33
Total Current Assets	2,588	2,695	3,121	3,166	1,579	1,646
Property, Plant & Equipment	3,024	2,585	1,618	1,311	1,183	1,094
Long-Term Investments	-	-	0.03	0.4	-	-
Other Intangible Assets	189.89	188.16	192.31	109.81	111.8	71.9
Long-Term Deferred Tax Assets	84.07	83.18	81.13	58.6	61.46	42.43
Long-Term Deferred Charges	12.62	9.61	10.99	12.38	4.04	7.47
Other Long-Term Assets	36.17	42.11	66.05	21.95	12.45	47.76
Total Assets	5,934	5,603	5,090	4,680	2,952	2,909
Accounts Payable	274.36	250.13	138.07	108.55	121.11	137.47
Accrued Expenses	80.59	125.76	115.86	112.97	100.66	93.75
Short-Term Debt	-	16.06	100.07	-	300.3	300.31
Current Portion of Long-Term Debt	26.48	10.1	-	-	14.02	5.01
Current Portion of Leases	-	3.28	3.12	3.42	3.33	-
Current Income Taxes Payable	31.18	23.45	30.68	0.5	49.01	23.07
Current Unearned Revenue	11.77	24.02	21.1	23.34	19.71	27.33
Other Current Liabilities	48.23	56.98	52.42	62.4	68.92	902.44
Total Current Liabilities	472.6	509.78	461.33	311.18	677.06	1,489
Long-Term Debt	344.7	117.43	-	-	26.04	40.06
Long-Term Leases	0.74	1.82	5.1	4.65	7.98	-
Long-Term Unearned Revenue	331	358.37	390.79	306.16	332.49	224.64
Total Liabilities	1,149	987.41	857.21	621.98	1,044	1,754
Common Stock	437.78	437.78	437.78	437.78	394	394
Additional Paid-In Capital	2,002	1,997	1,987	1,977	493.58	483.64
Retained Earnings	2,406	2,241	1,808	1,643	1,021	277.23
Treasury Stock	-60.01	-60.01	-	-	-	-
Shareholders' Equity	4,785	4,616	4,233	4,058	1,909	1,155
Total Liabilities & Equity	5,934	5,603	5,090	4,680	2,952	2,909
Total Debt	371.92	148.69	108.29	8.07	351.68	345.37
Net Cash (Debt)	1,153	1,411	2,200	2,292	365.41	673.97
Net Cash Growth	-29.58%	-35.84%	-4.03%	527.19%	-45.78%	-8.45%
Net Cash Per Share	2.65	3.23	5.04	5.56	0.93	1.71
Filing Date Shares Outstanding	435.17	435.17	436.41	437.78	394	394
Total Common Shares Outstanding	435.17	435.17	437.78	437.78	394	394
Working Capital	2,115	2,186	2,660	2,855	902.34	156.21
Book Value Per Share	11.00	10.61	9.67	9.27	4.84	2.93
Tangible Book Value	4,595	4,428	4,041	3,948	1,797	1,083
Tangible Book Value Per Share	10.56	10.17	9.23	9.02	4.56	2.75
Buildings	-	847.28	655.11	596.5	552.3	489.39
Machinery	-	1,499	1,257	1,189	1,056	875.34
Construction In Progress	-	1,117	435.37	122.64	51.69	138.29

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.